🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Some experts stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Material Removal

According to the social media company, the service has taken down violative material and banned associated hashtags and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.

Within moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, messages display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.